Simon Hirst

Simon is Sygnature’s founder, Chief Executive Officer and chair of the Board of Directors. He is a medicinal chemist with 30 years’ experience in the pharmaceutical industry. Simon has been engaged in the full spectrum of drug discovery activities – from high-throughput screening, to progressing hit-to-lead campaigns and all the way to successful lead optimisation projects and candidate drug selection. He has a broad experience of research in both a large pharmaceutical company (AstraZeneca) and a mid-size biotech (OSI Pharmaceuticals) as well as in a more commercial environment at CombiPure Ltd., where he was Managing Director and Director of Chemistry.

Simon has a BSc (Hons.) in chemistry and a PhD in synthetic organic chemistry from the University of Nottingham, and undertook post-doctoral research at the University of Pittsburgh.